Fraud, Access, and the Future of Telemedicine.
COVID-19
Fraud
Health Services Accessibility
Pandemics
Telemedicine
United States Department of Health and Human Services
Journal
Journal of the American Board of Family Medicine : JABFM
ISSN: 1558-7118
Titre abrégé: J Am Board Fam Med
Pays: United States
ID NLM: 101256526
Informations de publication
Date de publication:
11 Oct 2023
11 Oct 2023
Historique:
received:
08
02
2023
revised:
18
05
2023
accepted:
25
05
2023
pubmed:
30
9
2023
medline:
30
9
2023
entrez:
29
9
2023
Statut:
ppublish
Résumé
On July 20, 2022, the Department of Health and Human Services, Office of Inspector General (HHS-OIG), issued a Special Fraud Alert warning healthcare providers of increased fraudulent activity surrounding telemedicine companies. The Alert marks a further escalation of a multi-year effort by the Department of Justice (DOJ) and the HHS-OIG to crack down on multi-billion dollar fraud cases involving telehealth companies. It is the objective of this Commentary to place the HHS-OIG Special Fraud Alert in the context of enforcement efforts by the DOJ and HHS to stem the recent growth in telehealth fraud resulting from the COVID-19 pandemic. Taken together, it is apparent this is a critical moment in the evolution of telehealth and it is crucial to strike a proper balance between effective regulation and enforcement on the one hand, and access to care on the other.
Identifiants
pubmed: 37775323
pii: jabfm.2023.230044R1
doi: 10.3122/jabfm.2023.230044R1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
864-866Informations de copyright
© Copyright by the American Board of Family Medicine.